Investigative Trial of Interferon Alpha-2b To Shrink Cancer of the Eye
NCT00621439
·
clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
no funding- study never began
Conditions
Ocular Melanoma
Interventions
DRUG:
Pegylated Interfon Alpha 2B
DRUG:
Placebo
Sponsor
Emory University